Shaji Kumar, MD, Mayo
Advertisement
Articles by Shaji Kumar, MD, Mayo
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
Durvalumab Plus Enfortumab Vedotin Improves Survival in Cisplatin-Ineligible MIBC
2
DeLLphi-305 Data Support Frontline Maintenance Tarlatamab Plus Durvalumab as a New SOC in ES-SCLC
3
Pembrolizumab Plus Radiation Fails to Improve Recurrence-Free Survival in Early-Stage High-Intermediate–Risk dMMR Endometrial Cancer
4
LK101 Plus Tislelizumab Elicits Responses in Advanced NSCLC
5